Structure based virtual screening, docking and molecular dynamic simulation studies to identify potent mdm2-p53 inhibitors: Future implications for cancer therapy

Objective: To identify the p53 binding pocket as well as active residues in mdm2 protein, and search for similar (or) better compounds to inhibit mdm2-p53 interactions in comparison to FDA approved drug (Nutlin) by ligand and structure based virtual screening methods, docking, and molecular dynamic...

Full description

Bibliographic Details
Main Authors: B Vijay Raj, M V Raghavendra Rao, Yogesh Acharya
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Acta Medica International
Subjects:
Online Access:http://www.actamedicainternational.com/article.asp?issn=2349-0578;year=2017;volume=4;issue=1;spage=11;epage=21;aulast=Raj